| Adverse effects | Group A | Group B | Test | P-value | Group C | Group D | Test | P-value |
| Hypotension episodes | 5 [2 - 6] | 2 [2 - 3] | 164.5 | 0.004** | 9 [5 - 10] | 3 [2 - 6] | 129.5 | <0.001** |
| Nausea | 6 (24%) | 2 (8%) | X2 = 2.3 | 0.12 | 8 (32%) | 3 (12%) | X2 = 2.9 | 0.08 |
| Vomiting | 2 (8%) | 1 (4%) | X2 = 0.35 | 0.55 | 1 (4%) | 0 (0%) | X2 = 1.08 | 0.29 |
| Pruritis | 4 (16%) | 3 (12%) | X2 = 0.16 | 0.68 | 15 (60%) | 14 (56%) | X2 = 0.08 | 0.77 |
| No. of cases with no vasopressors | 1 (4%) | 6 (24%) | X2 = 4.4 | 0.03* | 0 (0%) | 4 (16%) | X2 = 4.3 | 0.04* |
| Incidence of hypotension | 96% | 76% |
|
| 100% | 84% |
|
|
| APGAR score |
|
|
|
|
|
|
|
|
| 1 min. | 7.16 ± 0.624 | 7.36 ± 0.64 | 1.12 | 0.26 | 7.24 ± 0.72 | 7.4 ± 0.70 | 0.79 | 0.43 |
| 5 min. | 9.36 ± 0.49 | 9.44 ± 0.5 | 0.56 | 0.57 | 9.4 ± 0.5 | 9.52 ± 0.51 | 0.84 | 0.4 |